Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
04/2000
04/11/2000US6048898 Synthesis of glatiramer acetate (copolymer-1)
04/11/2000US6048896 For treatment of brain or nervous system disorders
04/11/2000US6048891 Administering mixtures with 6-hydroxy-2,7,8-trimethyl-chroman-2-propanoic acid for treatment of cardiovascular and kidney disorders
04/11/2000US6048880 Therapy for cytokine sensitive diseases
04/11/2000US6048879 Dietetics
04/11/2000US6048873 Skin disorders
04/11/2000US6048868 Melatonin-antagonist β-carboline derivatives and analogues thereof containing naphthalenic structure, process for their preparation and their use as medicinal products
04/11/2000US6048853 Psychological disorders; nervous system disorders
04/11/2000US6048523 Polyester cyclic compounds, their complexes and bonded bodies
04/11/2000CA2094890C Antidepressant-3-halophenylpiperazinyl-propyl derivatives of substituted triazolones and triazoldiones
04/11/2000CA2009503C Ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2-hydroxyacids
04/08/2000CA2285120A1 Heterocycles
04/06/2000WO2000019210A2 Determining the mechanism of beta-amyloid peptide generation
04/06/2000WO2000018919A1 Human kinesin-like motor protein
04/06/2000WO2000018917A2 α-SYNUCLEIN SUPER-MUTANTS ACCELERATE α-SYNUCLEIN AGGREGATION
04/06/2000WO2000018915A2 Membrane-associated organizational proteins
04/06/2000WO2000018902A1 Method of screening for large offspring syndrome
04/06/2000WO2000018895A1 Short peptides which selectively modulate the activity of protein kinases
04/06/2000WO2000018801A2 Ncam binding compounds
04/06/2000WO2000018799A1 Artemin, a novel neurotrophic factor
04/06/2000WO2000018794A1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
04/06/2000WO2000018790A1 Synthesis of cyclic peptides
04/06/2000WO2000018767A2 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands
04/06/2000WO2000018764A1 Benzimidazolinyl piperidines as cgrp ligands
04/06/2000WO2000018760A1 1,3-benzodiazepines with integrin inhibitory activity for use in the treatment of inflammatory disorders
04/06/2000WO2000018759A1 Phenylalanine derivatives as alpha 4 integrin inhibitors
04/06/2000WO2000018758A1 Pyrimidone derivatives
04/06/2000WO2000018753A1 2-phenylpyran-4-one derivatives
04/06/2000WO2000018744A1 Oxazole compounds as prostaglandin e2 agonists or antagonists
04/06/2000WO2000018735A1 2-substituted heterocyclic sulfonamides
04/06/2000WO2000018733A1 Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals
04/06/2000WO2000018438A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof
04/06/2000WO2000018431A1 Chemokine receptor peptide vaccines for treatment and prevention of diabetes
04/06/2000WO2000018425A1 Use of substances with oxytocin activity in order to create well-being
04/06/2000WO2000018424A1 Use of substances with oxytocin activity in order to create cell regeneration
04/06/2000WO2000018415A1 Pharmaceutically active plant preparation for the treatment of migraine
04/06/2000WO2000018409A1 Use of certain drugs for treating nerve root injury
04/06/2000WO2000018408A1 2-methyl-thieno-benzodiazepine formulation
04/06/2000WO2000018406A1 Oral dosage formulations comprising (2s,3s,5r) -2-(3,5- difluorophenyl) -3,5-dimethyl -2-morpholinol and an effective stabilizing amount of alginic acid
04/06/2000WO2000018405A1 Use of prostanoid antagonists for the treatment of primary headache disorders
04/06/2000WO2000018400A1 Use of 3-(1h-imidazol-4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration
04/06/2000WO2000018369A1 Iontophoretic devices comprising piperidin derivatives
04/06/2000WO2000018365A2 Fast dissolving orally consumable films
04/06/2000WO2000018352A2 A method for treating inflammatory diseases by administering a thrombin inhibitor
04/06/2000WO2000018351A2 Aglyco products and methods of use
04/06/2000WO1999066914A3 Neuroprotective composition for the prevention and/or treatment of nervous and behavioural alterations due to anxiety states or depression, comprising acetyl-l-carnitine and hypericin
04/06/2000WO1999064596A3 Proteins regulating gene expression
04/06/2000WO1999064421A8 Acetylcholine enhancers
04/06/2000WO1999062505A3 Method for treating neurodegenerative disorders
04/06/2000WO1999045907A3 Metal chelators for use in the treatment of alzheimer's disease
04/06/2000WO1999037294A3 Mitochondria protecting agents for treating mitochondria associated diseases
04/06/2000CA2794705A1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
04/06/2000CA2714449A1 Use of certain drugs for treating nerve root injury
04/06/2000CA2345978A1 Chemokine receptor peptide vaccines for treatment and prevention of diabetes
04/06/2000CA2345944A1 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands
04/06/2000CA2345641A1 A method for treating inflammatory diseases by administering a thrombin inhibitor
04/06/2000CA2345638A1 Oral dosage formulations comprising (2s,3s,5r) -2-(3,5- difluorophenyl) -3,5-dimethyl -2-morpholinol and an effective stabilizing amount of alginic acid
04/06/2000CA2345474A1 Oxazole compounds as prostaglandin e2 agonists or antagonists
04/06/2000CA2345415A1 Pharmaceutically active plant preparation for the treatment of migraine
04/06/2000CA2345407A1 Synthesis of cyclic peptides
04/06/2000CA2345357A1 Benzimidazolinyl piperidines as cgrp ligands
04/06/2000CA2345065A1 Pyrimidone derivatives
04/06/2000CA2344873A1 2-methyl-thieno-benzodiazepine formulation
04/06/2000CA2344658A1 Human kinesin-like motor protein
04/06/2000CA2344104A1 Method of screening for large offspring syndrome
04/06/2000CA2343975A1 Ncam binding compounds
04/06/2000CA2343934A1 Short peptides which selectively modulate the activity of protein kinases
04/06/2000CA2343929A1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
04/06/2000CA2343927A1 Artemin, a novel neurotrophic factor
04/06/2000CA2343696A1 Membrane-associated organizational proteins
04/06/2000CA2341763A1 Antigenic peptides of aglyco 10b and antibodies thereto
04/06/2000CA2338442A1 Phenylalanine derivatives as alpha 4 integrin inhibitors
04/06/2000CA2311462A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof
04/05/2000EP0990655A1 Method for drying anhydrous paroxetine hydrochloride
04/05/2000EP0990031A2 Tumor necrosis factor receptor 5
04/05/2000EP0989995A2 Torsin, torsin genes, and methods of use
04/05/2000EP0989993A1 Tartrate salt of a substituted dipeptide as growth hormone secretagogue
04/05/2000EP0989987A1 Spiro-azacyclic derivatives and their use as therapeutic agents
04/05/2000EP0989986A1 5,7-disubstituted 4-aminopyrido 2,3-d]pyrimidine compounds and their use as adenosine kinase inhibitors
04/05/2000EP0989985A1 Fused polycyclic 2-aminopyrimidine derivatives as protein kinase inhibitors
04/05/2000EP0989975A1 Oxazole compounds useful as pge2 agonists and antagonists
04/05/2000EP0989859A1 Cns neuroregenerative compositions and methods of use
04/05/2000EP0989850A1 Use of pramipexole in the treatment of restless legs syndrome
04/05/2000EP0777740B1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle
04/05/2000EP0777739B1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle
04/05/2000EP0750631B1 Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo(c)azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace
04/05/2000EP0738147B1 Application of riluzole in the treatment of mitochondrial diseases
04/05/2000EP0716661B1 Pseudo- and non-peptide bradykinin receptor antagonists
04/05/2000CN1249750A Crystalline hydrated sodium salt of (E)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1H-indole-2-carboxylic acid
04/05/2000CN1249690A Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1
04/05/2000CN1249686A Paroxetine compositions
04/05/2000CN1249685A Use of levobupivacaine or ropivacaine in treating migraine
04/05/2000CN1249684A Use of levobupivacaine in facial surgery
04/05/2000CN1249683A Use of leveobupivacaine in paediatric surgery
04/05/2000CN1249681A N-oxides of heterocyclic esters, amides, thioesters, and ketones
04/05/2000CN1249194A Medical capsule for treating toothache
04/05/2000CN1051086C Heterocycle-condensed morphinoid derivs. and use thereof
04/05/2000CN1051085C Substed. dihydropyranopyridines, their preparation process, use and pharmaceutical composition contg. same
04/05/2000CN1051079C Benzodiazepine derivs. their preparation method and pharmaceutical composition contg. same
04/05/2000CN1050993C Drug with effect of resisting and preventing tension and intelligence promoting
1 ... 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 ... 1833